ES2154828T3 - Uso de derivados de fenoxipiridina para el tratamiento de enfermedades causadas por trastornos del sistema dopamina. - Google Patents
Uso de derivados de fenoxipiridina para el tratamiento de enfermedades causadas por trastornos del sistema dopamina.Info
- Publication number
- ES2154828T3 ES2154828T3 ES96921928T ES96921928T ES2154828T3 ES 2154828 T3 ES2154828 T3 ES 2154828T3 ES 96921928 T ES96921928 T ES 96921928T ES 96921928 T ES96921928 T ES 96921928T ES 2154828 T3 ES2154828 T3 ES 2154828T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- carbonyl
- amino
- hydrogen
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Abstract
LA INVENCION SE REFIERE AL USO DE COMPUESTOS DE FORMULA GENERAL (I), EN DONDE R SUP,1} SIGNIFICA HIDROGENO, ALQUILO INFERIOR, HALOGENO, ALCOXI INFERIOR O NITRO; R SUP,2} SIGNIFICA HIDROGENO, ALQUILO INFERIOR O TRIFLUOROMETILO; Y R SUP,3} SIGNIFICA HIDROGENO, ALQUILO INFERIOR, TRIFLUOROMETILO, BENCILO, HIDROXI ALQUILO INFERIOR, ALCOXI INFERIOR, ALQUIL INFERIOR - CARBONIL AMINO, CARBONIL - ALQUILO INFERIOR, BENCILO, DI - ALQUIL INFERIOR - AMINO - CARBONILO, CARBONILAMINO O AMINO - CARBONIL AMINO; O R SUP,2} Y R SUP,3} JUNTOS OPCIONALMENTE SIGNIFICAN UN ANILLO BENCENO FUNDIDO Y R SUP,4} SIGNIFICA HIDROGENO O HALOGENO, ASI COMO TAMBIEN SALES FARMACEUTICAMENTE ACEPTABLES DE COMPUESTOS DE LA FORMULA GENERAL (I), PARA EL TRATAMIENTO O LA PROFILAXIS DE ENFERMEDADES PRODUCIDAS POR TRASTORNOS DEL SISTEMA DE LA DOPAMINA Y, RESPECTIVAMENTE, PARA LA PRODUCCION DE LOS MEDICAMENTOS CORRESPONDIENTES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH170495 | 1995-06-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2154828T3 true ES2154828T3 (es) | 2001-04-16 |
Family
ID=4216657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96921928T Expired - Lifetime ES2154828T3 (es) | 1995-06-09 | 1996-06-04 | Uso de derivados de fenoxipiridina para el tratamiento de enfermedades causadas por trastornos del sistema dopamina. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5698565A (es) |
EP (1) | EP0837680B1 (es) |
JP (1) | JP3004732B2 (es) |
AT (1) | ATE198984T1 (es) |
AU (1) | AU6300396A (es) |
BR (1) | BR9609196A (es) |
CA (1) | CA2222226A1 (es) |
DE (1) | DE69611727T2 (es) |
DK (1) | DK0837680T3 (es) |
ES (1) | ES2154828T3 (es) |
GR (1) | GR3035703T3 (es) |
PT (1) | PT837680E (es) |
TR (1) | TR199701577T1 (es) |
WO (1) | WO1996041629A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR199801774T2 (xx) * | 1996-03-08 | 1998-12-21 | F.Hoffmann-La Roche Ag | 4-fenil-3, 6-dihidro-2H- piridil t�revlerinin, NMDA resept�r alttip blokerleri olarak kullan�m�. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL133317C (es) * | 1966-06-24 | 1900-01-01 | ||
US3816434A (en) * | 1966-06-24 | 1974-06-11 | Hoffmann La Roche | 4-(3-(4-phenyl-piperidino)-2-hydroxy-propoxy)-benzophenones |
CH474511A (es) * | 1966-06-24 | 1969-06-30 | F. Hoffmann-La Roche & Co. Aktiengesellschaft | |
CH506525A (de) * | 1968-12-24 | 1971-04-30 | Hoffmann La Roche | Verfahren zur Herstellung von aromatischen Äthern |
CH558354A (de) * | 1970-06-17 | 1975-01-31 | Hoffmann La Roche | Verfahren zur herstellung von aromatischen aethern. |
JPS57145872A (en) * | 1981-03-05 | 1982-09-09 | Otsuka Pharmaceut Co Ltd | Carbostyrile derivative |
FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
HU211019B (en) * | 1991-12-02 | 1995-09-28 | Richter Gedeon Vegyeszet | Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds |
-
1996
- 1996-04-29 US US08/639,386 patent/US5698565A/en not_active Expired - Fee Related
- 1996-06-04 CA CA002222226A patent/CA2222226A1/en not_active Abandoned
- 1996-06-04 ES ES96921928T patent/ES2154828T3/es not_active Expired - Lifetime
- 1996-06-04 EP EP96921928A patent/EP0837680B1/en not_active Expired - Lifetime
- 1996-06-04 AU AU63003/96A patent/AU6300396A/en not_active Abandoned
- 1996-06-04 DK DK96921928T patent/DK0837680T3/da active
- 1996-06-04 AT AT96921928T patent/ATE198984T1/de not_active IP Right Cessation
- 1996-06-04 PT PT96921928T patent/PT837680E/pt unknown
- 1996-06-04 WO PCT/EP1996/002430 patent/WO1996041629A1/en active IP Right Grant
- 1996-06-04 BR BR9609196A patent/BR9609196A/pt not_active Application Discontinuation
- 1996-06-04 TR TR97/01577T patent/TR199701577T1/xx unknown
- 1996-06-04 DE DE69611727T patent/DE69611727T2/de not_active Expired - Fee Related
- 1996-06-04 JP JP9502585A patent/JP3004732B2/ja not_active Expired - Lifetime
-
2001
- 2001-04-05 GR GR20010400551T patent/GR3035703T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0837680B1 (en) | 2001-01-31 |
ATE198984T1 (de) | 2001-02-15 |
DE69611727D1 (de) | 2001-03-08 |
BR9609196A (pt) | 1999-05-11 |
DK0837680T3 (da) | 2001-05-07 |
US5698565A (en) | 1997-12-16 |
AU6300396A (en) | 1997-01-09 |
JP3004732B2 (ja) | 2000-01-31 |
PT837680E (pt) | 2001-07-31 |
TR199701577T1 (xx) | 1998-06-22 |
JPH10506651A (ja) | 1998-06-30 |
DE69611727T2 (de) | 2001-08-23 |
CA2222226A1 (en) | 1996-12-27 |
WO1996041629A1 (en) | 1996-12-27 |
MX9709393A (es) | 1998-07-31 |
EP0837680A1 (en) | 1998-04-29 |
GR3035703T3 (en) | 2001-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9307062A (es) | Derivado de quinuclidina para el tratamiento de los trastornos inflamatorios y del sistema nervioso central. | |
MX9300552A (es) | Derivados de etanolamina | |
GEP20012389B (en) | Benzoxazinone Dopamine D4 Receptor Antagonists, Pharmaceutical Composition Containing the Same and Method for Treatment of Psychosis or Schizophrenia | |
FI945581A0 (fi) | Substituoidut (aryylialkoksibentsyyli) aminopropaaniamidijohdannaiset, niiden valmistus ja käyttö antiepileptisinä, neuroprotektiivisina ja antidepressiivisinä aineina | |
ES512574A0 (es) | "procedimiento de preparacion de derivados carboxilato". | |
FI945582A0 (fi) | Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina | |
NO308658B1 (no) | Sammenføyde isoquinoliner som dopamin-reseptor-ligander | |
CA2423628A1 (en) | Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them | |
ES2154828T3 (es) | Uso de derivados de fenoxipiridina para el tratamiento de enfermedades causadas por trastornos del sistema dopamina. | |
ITTO930661A1 (it) | Derivati acidi poliamidici ad attivita' antigastrinica, procedimento per la loro preparazione e loro uso farmaceutico. | |
ES2122274T3 (es) | Derivados de pirido(1,2,3-de)quinoxalina, procedimiento para su produccion y su uso en medicamentos. | |
WO1994016705A3 (en) | Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders | |
KR920011491A (ko) | 헥사히드로-8-히드록시-2, 6-메타노-2h-퀴놀리진-3(4h)-온 및 관련 화합물의 특정 에스테르를 함유하는 인식 장애 치료용 제약 조성물 | |
PA8505301A1 (es) | Metodo para tratar el mal de parkinson a traves de la administracion de ( - ) - 5 ceto-2-n- propilamino - tetrahidrotetralina | |
AR014936A1 (es) | Compuesto de bencimidazol sustituido en la posicion 5,composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento | |
AR011138A1 (es) | Compuestos derivados de 4-aminoalcoxi-1,3-dihidrobenzomidazol-2-onas, composicion farmaceutica que los comprende y uso de los mismos para lafabricacion de un medicamento util, agonistas del autorreceptor de la dopamina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 837680 Country of ref document: ES |